Collaboration Mode
Novastage Pharmaceuticals has a globally leading transdermal patch technology platform and an experienced professional team. The cooperation in the following fields are welcome. We also undertake CRO commissioned development of transdermal patches.
505(b)(2):
NOVA1010: Risperidone transdermal patch, used for the treatment of schizophrenia, 1 patch per week, IND in the United States has been approved by FDA.
Chinese or/and international first generic drug:
NOVA2001: Used to treat Parkinson's disease, 1 patch every 24 hours and pre PK-BE equivalent;
NOVA2003: Used to treat pain such as joint pain, BE-ready.
Contact person: Mr. Tang
Phone No.: 15338803475
Contact person: Mr. Xiao
Phone No.: 13510286263